Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
Objective: This study aims to evaluate and compare the effects of suprachoroidal and intravitreal triamcinolone administration, as a primary treatment, on best corrected visual acuity (BCVA), central macular thickness (CMT), and intraocular pressure (IOP) in patients with diabetic macular edema (DM...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rawalpindi Medical University
2023-12-01
|
| Series: | Journal of Rawalpindi Medical College |
| Subjects: | |
| Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/2430 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832086907917434880 |
|---|---|
| author | Fatima Shafqat Khan Asfandyar Asghar Brig Rana Intisar-ul-haq Tehmina Nazir Naila Obaid Munazza Aslam |
| author_facet | Fatima Shafqat Khan Asfandyar Asghar Brig Rana Intisar-ul-haq Tehmina Nazir Naila Obaid Munazza Aslam |
| author_sort | Fatima Shafqat Khan |
| collection | DOAJ |
| description |
Objective: This study aims to evaluate and compare the effects of suprachoroidal and intravitreal triamcinolone administration, as a primary treatment, on best corrected visual acuity (BCVA), central macular thickness (CMT), and intraocular pressure (IOP) in patients with diabetic macular edema (DME).
Methods: A quasi-experimental study was conducted from November 2022 to April 2023. 64 eyes were enrolled with Inclusion criteria comprising patients with diabetic macular edema (DME) (central involving) with BCVA < 6/9, CMT > 300 µm on optical coherence tomography (OCT), and no prior DME treatment. Patients were divided into suprachoroidal triamcinolone (SCTA) (Group I) and intravitreal triamcinolone (IVTA) (Group II) groups. Follow-up occurred at 1 week, 1 month, and 3 months post-injection. BCVA, CMT, and IOP were recorded. Data were analyzed using SPSS with a significance threshold of p < 0.05.
Results: Both treatment groups exhibited improved BCVA and reduced CMT. Suprachoroidal delivery demonstrated more substantial visual acuity improvements compared to the intravitreal group. Reduction in IOP was observed in the suprachoroidal group at 1stweek post-treatment (p<0.001), while the intravitreal group experienced increased IOP at later follow-ups (p<0.001).
Conclusion: This study illuminates the efficacy of both suprachoroidal and intravitreal triamcinolone administration as the primary treatment for DME. While both modalities displayed promising outcomes, suprachoroidal delivery exhibited more substantial visual acuity improvements with fewer side effects and promising alternatives for DME treatment.
Keywords: Macular Edema, Intravitreal, Triamcinolone Acetonide, Suprachoroidal, Visual Acuity, Intraocular Pressure.
|
| format | Article |
| id | doaj-art-30c062f4ad0d49a784873907e8a7c5c2 |
| institution | Kabale University |
| issn | 1683-3562 1683-3570 |
| language | English |
| publishDate | 2023-12-01 |
| publisher | Rawalpindi Medical University |
| record_format | Article |
| series | Journal of Rawalpindi Medical College |
| spelling | doaj-art-30c062f4ad0d49a784873907e8a7c5c22025-02-06T08:39:43ZengRawalpindi Medical UniversityJournal of Rawalpindi Medical College1683-35621683-35702023-12-0127410.37939/jrmc.v27i4.2430Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular EdemaFatima Shafqat Khan0Asfandyar AsgharBrig Rana Intisar-ul-haq Tehmina NazirNaila Obaid Munazza AslamFoundation University of Health Sciences (FUSH) Objective: This study aims to evaluate and compare the effects of suprachoroidal and intravitreal triamcinolone administration, as a primary treatment, on best corrected visual acuity (BCVA), central macular thickness (CMT), and intraocular pressure (IOP) in patients with diabetic macular edema (DME). Methods: A quasi-experimental study was conducted from November 2022 to April 2023. 64 eyes were enrolled with Inclusion criteria comprising patients with diabetic macular edema (DME) (central involving) with BCVA < 6/9, CMT > 300 µm on optical coherence tomography (OCT), and no prior DME treatment. Patients were divided into suprachoroidal triamcinolone (SCTA) (Group I) and intravitreal triamcinolone (IVTA) (Group II) groups. Follow-up occurred at 1 week, 1 month, and 3 months post-injection. BCVA, CMT, and IOP were recorded. Data were analyzed using SPSS with a significance threshold of p < 0.05. Results: Both treatment groups exhibited improved BCVA and reduced CMT. Suprachoroidal delivery demonstrated more substantial visual acuity improvements compared to the intravitreal group. Reduction in IOP was observed in the suprachoroidal group at 1stweek post-treatment (p<0.001), while the intravitreal group experienced increased IOP at later follow-ups (p<0.001). Conclusion: This study illuminates the efficacy of both suprachoroidal and intravitreal triamcinolone administration as the primary treatment for DME. While both modalities displayed promising outcomes, suprachoroidal delivery exhibited more substantial visual acuity improvements with fewer side effects and promising alternatives for DME treatment. Keywords: Macular Edema, Intravitreal, Triamcinolone Acetonide, Suprachoroidal, Visual Acuity, Intraocular Pressure. https://www.journalrmc.com/index.php/JRMC/article/view/2430Keywords: Central macular thickness, Diabetic macular edema, Intravitreal triamcinolone, Suprachoroidal administration, Visual acuity |
| spellingShingle | Fatima Shafqat Khan Asfandyar Asghar Brig Rana Intisar-ul-haq Tehmina Nazir Naila Obaid Munazza Aslam Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema Journal of Rawalpindi Medical College Keywords: Central macular thickness, Diabetic macular edema, Intravitreal triamcinolone, Suprachoroidal administration, Visual acuity |
| title | Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema |
| title_full | Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema |
| title_fullStr | Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema |
| title_full_unstemmed | Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema |
| title_short | Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema |
| title_sort | suprachoroidal versus intravitreal injection of triamcinolone acetonide as primary treatment for diabetic macular edema |
| topic | Keywords: Central macular thickness, Diabetic macular edema, Intravitreal triamcinolone, Suprachoroidal administration, Visual acuity |
| url | https://www.journalrmc.com/index.php/JRMC/article/view/2430 |
| work_keys_str_mv | AT fatimashafqatkhan suprachoroidalversusintravitrealinjectionoftriamcinoloneacetonideasprimarytreatmentfordiabeticmacularedema AT asfandyarasghar suprachoroidalversusintravitrealinjectionoftriamcinoloneacetonideasprimarytreatmentfordiabeticmacularedema AT brigranaintisarulhaq suprachoroidalversusintravitrealinjectionoftriamcinoloneacetonideasprimarytreatmentfordiabeticmacularedema AT tehminanazir suprachoroidalversusintravitrealinjectionoftriamcinoloneacetonideasprimarytreatmentfordiabeticmacularedema AT nailaobaid suprachoroidalversusintravitrealinjectionoftriamcinoloneacetonideasprimarytreatmentfordiabeticmacularedema AT munazzaaslam suprachoroidalversusintravitrealinjectionoftriamcinoloneacetonideasprimarytreatmentfordiabeticmacularedema |